Blue Owl Capital Holdings »

Lenz Therapeutics shares owned by Blue Owl Capital Holdings

Quarter-by-quarter ownership of Lenz Therapeutics (LENZ) shares owned by Blue Owl Capital Holdings from 13F filings

Historical chart of Blue Owl Capital Holdings investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by Blue Owl Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by Blue Owl Capital Holdings

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.3M 757k 5.68
2026-03-31 $4.6M 507k 9.15
2025-12-31 $2.4M 150k 16.00

More positions owned by Blue Owl Capital Holdings

Space Exploration Techn Corp Class A Com Stk (SPCX)
Aktis Oncology (AKTS)
Cullinan Oncology (CGEM)
Larimar Therapeutics (LRMR)
Nuveen Churchill Direct Lend Com Shs (NCDL)
Maplight Therapeutics (MPLT)
Capital One Financial (COF)
Owl Rock Capital Corporation (OBDC)
Deep Fission Ord
Dell Technologies CL C (DELL)
Holley (HLLY)
Eyepoint Com New (EYPT)
Sagimet Biosciences Com Ser A (SGMT)
Corvus Pharmaceuticals (CRVS)
Artiva Biotherapeutics (ARTV)

View all positions for Blue Owl Capital Holdings

Top funds holding Lenz Therapeutics

RA Capital Management
Falcon Edge Capital
FMR
Versant Venture Management
BlackRock
Standard Life Aberdeen
Squarepoint Ops
Franklin Resources
Vanguard Capital Management
72 Investment Holdings
Millennium Management
Blue Owl Capital Holdings
CAM Group Holding A/S
Morgan Stanley
Bank of America Corporation

View all funds holding Lenz Therapeutics